Chematria

Chematria

Chematria

Atomwise develops artificial intelligence systems using powerful deep learning algorithms and supercomputers for drug discovery.
Type
B2c
Founded
2012
Raised
$168.3M
Follow us
Alexa global traffic share
Twitter followers
Latest funding Show all
$123,000,000
Venture capital (Series B) - 2020
AME Cloud Ventures Tencent Holdings Dolby Family Ventures +5
$45,000,000
Venture capital (Series A) - 2018
Khosla Ventures Data Collective DFJ Growth +6
Team Size
10+
Employees
$123,000,000 Venture capital (Series B)
DealStreetAsia

Tencent-backed US drug discovery firm Atomwise closes $123m Series B round